Sartorius strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenix ...Middle East

PR Newswire - Economy
Sartorius strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenix
GÖTTINGEN, Germany, July 2, 2021 /PRNewswire/ -- The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH. The company based in Freiburg, Germany, and with a sales subsidiary near the...

Read More Details
Finally We wish PressBee provided you with enough information of ( Sartorius strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenix )

Apple Storegoogle play

Also on site :

Most viewed in Economy


Latest News